The Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching Capabilities by nearly 300% with GenomOncology
Watch the Pancreatic Cancer Action Network (PanCAN) and GenomOncology teams break down how PanCAN utilized GenomOncology’s Clinical Trial Matching solution to streamline the organization’s biomarker-driven clinical trial matching process.
Over the 30-minute on-demand webinar, we will cover:
-
The challenges associated with utilizing the ever-evolving precision medicine data in patient treatment matching, and how GenomOncology’s clinical trial matching solution navigates through this growing data in order to streamline the matching of patients to accurate, relevant clinical trials.
-
How GenomOncology enabled PanCAN to increase the number of biomarker-driven searches by 300% and reduce the time spent on biomarker-driven clinical trial searches by 50%.
-
PanCAN’s upgrade to GenomOncology’s Precision Decision, which enables the PanCAN team to advance their treatment searching capabilities through the addition of the patient's prior intervention history.
Featured Presenter
James Cole has over a decade of experience in precision oncology, making him integral in GenomOncology's understanding of the field of clinical genomics. Cole works across GenomOncology’s Precision Oncology Platform (POP), ensuring all our precision oncology solutions include the necessary precision oncology data sets in order to inform decision support and streamline patient treatment analysis and research.